DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Locke F, Ghobadi A, Jacobson CA. et al.
Long‐term safety and activity of axicabtagene ciloleucel in refractory large B‐cell lymphoma (ZUMA‐1): a single‐arm, multicentre, phase 1–2 trial.

Lancet Oncol 2019;
20: 31-42

Download Bibliographical Data

Search in: